News

CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findingsA follow-up Phase 3 study will be discussed with regulatory authoritiesLUND ...
Camurus (NASDAQ STO: CAMX) today announced topline results from the 12-month, randomized, double-blind, placebo-controlled POSITANO Phase 2b study (NCT05281328), evaluating efficacy and safety of ...
In the most frequent wave of lifestyle-related ailments, fatty liver is topping the charts. Also known as hepatic steatosis, ...
A marathon liver transplant surgery was successfully performed on a 19-year-old man by the transplant team at Hippokration ...
New data from the Centers for Disease Control and Prevention shows Oregon is third worst in the nation for deaths from hepatitis C. While there is no vaccine available, it is treatable with proper ...
For the Mrozinksy family, the first few months of their 7-month-old son Logan's life have been focused on saving it.
Six out of ten people with type 2 diabetes had fatty liver in a new study from Linköping University in Sweden. Of these, only ...
Six out of 10 people with type 2 diabetes had fatty liver in a new study from Linköping University. Of these, only a small ...
Are your everyday habits damaging your liver? It’s not just alcohol – even sugar, painkillers, and sitting too much can take ...
In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more accurate.
Liver transplant is a lifesaving surgery, but a significant number of patients experience organ rejection or other ...